LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

Search

CVS Health Corp.

Slēgts

SektorsVeselības aprūpe

76.93 1.84

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

74.27

Max

76.93

Galvenie mērījumi

By Trading Economics

Ienākumi

-3.8B

-2.8B

Pārdošana

4B

103B

P/E

Sektora vidējais

199.395

121.746

Dividenžu ienesīgums

3.4

Peļņas marža

-2.722

Darbinieki

219,000

EBITDA

-4B

-1.6B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+27.02% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

3.40%

2.26%

Nākamie ieņēmumi

2026. g. 30. apr.

Nākamais dividenžu datums

2026. g. 30. apr.

Nākamais Ex dividenžu datums

2026. g. 21. apr.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-8.4B

96B

Iepriekšējā atvēršanas cena

75.09

Iepriekšējā slēgšanas cena

76.93

Ziņu noskaņojums

By Acuity

53%

47%

281 / 352 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bullish Evidence

CVS Health Corp. Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 10. febr. 11:45 UTC

Peļņas

CVS Profit, Revenue Climb as Turmoil Continues in Health-Insurance Sector

2026. g. 11. febr. 14:47 UTC

Peļņas

Humana Earnings Reveal Narrower-Than-Expected Loss. Why the Stock Is Falling. -- Barrons.com

2026. g. 11. febr. 12:04 UTC

Peļņas

Humana Loss Was Narrower Than Expected. Why the Stock Is Falling. -- Barrons.com

2026. g. 11. febr. 11:33 UTC

Peļņas

Humana Loss Was Less Than Expected. Why the Stock Is Falling. -- Barrons.com

2026. g. 11. febr. 11:33 UTC

Peļņas

Humana Loss Was Less Than Expected. Why the Stock Is Falling. -- Barrons.com

2026. g. 10. febr. 22:15 UTC

Peļņas

Humana Earnings Will Shed More Light on Medicare Prospects -- Barrons.com

2026. g. 10. febr. 21:24 UTC

Peļņas

These Stocks Are Today's Movers: Spotify, S&P Global, CVS, Coca-Cola, TSMC, Datadog, Kyndryl, Credo, and More -- Barrons.com

2026. g. 10. febr. 17:43 UTC

Peļņas

These Stocks Are Today's Movers: Spotify, S&P Global, CVS, Coca-Cola, TSMC, Datadog, Kyndryl, Credo, and More -- Barrons.com

2026. g. 10. febr. 15:06 UTC

Peļņas

These Stocks Are Today's Movers: Spotify, S&P Global, CVS, Coca-Cola, TSMC, Datadog, Upwork, Credo, and More -- Barrons.com

2026. g. 10. febr. 13:18 UTC

Peļņas

These Stocks Are Today's Movers: CVS, Spotify, Harley-Davidson, Coca-Cola, TSMC, BP, Datadog, S&P Global, and More -- Barrons.com

2026. g. 10. febr. 12:24 UTC

Peļņas

CVS Stock Drops After Earnings Beat. Why Medicare Worries Persist. -- Barrons.com

2026. g. 10. febr. 11:53 UTC

Peļņas

CVS Stock Falls After Earnings Beat. Why Medicare Worries Persist. -- Barrons.com

2026. g. 10. febr. 11:30 UTC

Peļņas

CVS Health 4Q Pharmacy & Consumer Wellness Segment Revenue $37.66B >CVS

2026. g. 10. febr. 11:30 UTC

Peļņas

CVS Health 4Q Health Services Segment Revenue $51.24B >CVS

2026. g. 10. febr. 11:30 UTC

Peļņas

CVS Health 4Q Healthcare Benefits Segment Revenue $36.29B >CVS

2026. g. 10. febr. 11:30 UTC

Peļņas

CVS Health 4Q Pharmacy Same-Store Sales Up 19.3% >CVS

2026. g. 10. febr. 11:30 UTC

Peļņas

CVS Health 4Q Same-Store Sales Up 16.0% >CVS

2026. g. 10. febr. 11:30 UTC

Peļņas

CVS Health 4Q Pharmacy & Consumer Wellness Segment Revenue Up 12.4% >CVS

2026. g. 10. febr. 11:30 UTC

Peļņas

CVS Health 4Q Healthcare Benefits Segment Revenue Up 10.1% >CVS

2026. g. 10. febr. 11:30 UTC

Peļņas

CVS Health 4Q Front Store Same-Store Sales Up 0.5% >CVS

2026. g. 10. febr. 11:30 UTC

Peļņas

CVS Health 4Q Net $2.94B >CVS

2026. g. 10. febr. 11:30 UTC

Peļņas

CVS Health 4Q EPS $2.30 >CVS

2026. g. 10. febr. 11:30 UTC

Peļņas

CVS Health 4Q Adj EPS $1.09 >CVS

2026. g. 10. febr. 11:30 UTC

Peļņas

CVS Health Sees FY Net $7.64B-Net $7.89B >CVS

2026. g. 10. febr. 11:30 UTC

Peļņas

CVS Health Sees FY EPS $5.94-EPS $6.14 >CVS

2026. g. 10. febr. 11:30 UTC

Peļņas

CVS Health 4Q Rev $105.7B >CVS

2026. g. 10. febr. 11:30 UTC

Peļņas

CVS Health 4Q Health Services Segment Revenue Up 9.0% >CVS

2026. g. 10. febr. 11:30 UTC

Peļņas

CVS Health Sees FY Adj EPS $7.00-Adj EPS $7.20 >CVS

2026. g. 10. febr. 11:30 UTC

Peļņas

CVS Health: Health Care Benefits Segment's 4Q Medical Benefit Ratio 94.8% >CVS

2026. g. 10. febr. 11:30 UTC

Peļņas

CVS Health 4Q Same-Store Prescription Volume Rose 9.7% On 30-Day Equivalent Basis >CVS

Salīdzinājums

Cenas izmaiņa

CVS Health Corp. Prognoze

Cenas mērķis

By TipRanks

27.02% augšup

Prognoze 12 mēnešiem

Vidējais 96.24 USD  27.02%

Augstākais 105 USD

Zemākais 90 USD

Pamatojoties uz 18 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi CVS Health Corp. — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

18 ratings

16

Pirkt

2

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

65.92 / 68.28Atbalsts un pretestība

Īstermiņā

Very Strong Bullish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

Weak Bullish Evidence

Noskaņojums

By Acuity

281 / 352 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par CVS Health Corp.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
help-icon Live chat